These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 29197968)

  • 21. Endovenous laser ablation of the great and short saphenous veins with a 1320-nm neodymium:yttrium-aluminum-garnet laser: retrospective case series of 1171 procedures.
    Moul DK; Housman L; Romine S; Greenway H
    J Am Acad Dermatol; 2014 Feb; 70(2):326-31. PubMed ID: 24314878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of 120-200 W 2 μm thulium:yttrium-aluminum-garnet vapoenucleation of the prostate.
    Netsch C; Bach T; Pohlmann L; Herrmann T; Gross AJ
    J Endourol; 2012 Mar; 26(3):224-9. PubMed ID: 22191688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predictive factors for local recurrence after glansectomy and neoglans reconstruction for penile squamous cell carcinoma.
    Albersen M; Parnham A; Joniau S; Sahdev V; Christodoulidou M; Castiglione F; Nigam R; Malone P; Freeman A; Jameson C; Minhas S; Ralph DJ; Muneer A
    Urol Oncol; 2018 Apr; 36(4):141-146. PubMed ID: 28882673
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of 5α-reductase inhibitors on the efficiency of thulium:yttrium-aluminium-garnet (RevoLix®) vaporesection for treating benign prostatic hyperplasia.
    Chung JS; Seo WI; Oh CK; Kim SC; Park MC; Park SH; Yu J; Lee CH; Kim W; Park TY; Min KS; Chung JI
    Investig Clin Urol; 2020 Jan; 61(1):67-74. PubMed ID: 31942465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thulium:yttrium-aluminum-garnet laser for en bloc resection of bladder cancer: clinical and histopathologic advantages.
    Muto G; Collura D; Giacobbe A; D'Urso L; Muto GL; Demarchi A; Coverlizza S; Castelli E
    Urology; 2014 Apr; 83(4):851-5. PubMed ID: 24548711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncological and Functional Outcomes After Organ-Sparing Plastic Reconstructive Surgery for Penile Cancer.
    Pérez J; Chavarriaga J; Ortiz A; Orrego P; Rueda S; Quiroga W; Fernandez N; Patiño G; Tobar V; Villareal N; Prada J; Barco C; Sarmiento G
    Urology; 2020 Aug; 142():161-165.e1. PubMed ID: 32380155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Penile-sparing surgery for patients with superficial or initially invasive squamous cell carcinoma of the penis: long-term oncological outcomes.
    Luzzago S; Serino A; Aurilio G; Mistretta FA; Piccinelli ML; Lorusso V; Morelli M; Bianchi R; Catellani M; Cozzi G; Di Trapani E; Cioffi A; Verri E; Ferro M; Cossu Rocca M; Matei DV; Nolè F; de Cobelli O; Musi G
    Urol Oncol; 2021 Oct; 39(10):736.e1-736.e7. PubMed ID: 34301457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Laser therapy of penile carcinoma].
    Rothenberger KH; Hofstetter A
    Urologe A; 1994 Jul; 33(4):291-4. PubMed ID: 7941174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penile carcinoma. Is Nd:YAG laser therapy radical enough?
    Frimberger D; Hungerhuber E; Zaak D; Waidelich R; Hofstetter A; Schneede P
    J Urol; 2002 Dec; 168(6):2418-21; discussion 2421. PubMed ID: 12441930
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distal urethrectomy for localized penile squamous carcinoma in situ extending into the urethra: an updated series.
    Pedrosa JA; Amstutz SP; Bihrle R; Mellon MJ
    Int Urol Nephrol; 2014 Aug; 46(8):1551-5. PubMed ID: 24633698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up.
    Schlenker B; Gratzke C; Seitz M; Bader MJ; Reich O; Schneede P; Hungerhuber E; Stief CG; Tilki D
    Urol Oncol; 2011; 29(6):788-93. PubMed ID: 19945305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Er:YAG laser brain surgery with vascular specific coagulation.
    Katta N; Estrada AD; McElroy AB; Milner TE
    Lasers Surg Med; 2022 Oct; 54(8):1107-1115. PubMed ID: 35946396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Squamous cell carcinoma of the penis in a circumcised man: a case for dermatology and urology, and review of the literature.
    Ross BS; Levine VJ; Dixon C; Ashinoff R
    Cutis; 1998 Jan; 61(1):41-3. PubMed ID: 9466082
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conservative treatment of penile carcinoma - a retrospective study of 10 years.
    Pereira N; Cabral AR; Vieira R; Figueiredo A
    An Bras Dermatol; 2013; 88(5):844-6. PubMed ID: 24173202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of early morbidity and functional outcome of thulium: yttrium-aluminum-garnet laser enucleation for benign prostate enlargement: patient age and prostate size determine adverse surgical outcome.
    Rausch S; Heider T; Bedke J; Kruck S; Schwentner C; Fischer K; Stenzl A; Kälble T
    Urology; 2015 Jan; 85(1):182-8. PubMed ID: 25530383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients.
    Bandieramonte G; Colecchia M; Mariani L; Lo Vullo S; Pizzocaro G; Piva L; Nicolai N; Salvioni R; Lezzi V; Stefanon B; De Palo G
    Eur Urol; 2008 Oct; 54(4):875-82. PubMed ID: 18243513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Laser therapy of carcinoma of the penis].
    Venkov G; Filev A
    Khirurgiia (Sofiia); 2006; (6):20-2. PubMed ID: 18843905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Endoscopic vaporesection of the prostate using the continuous-wave 2-microm thulium laser: outcome and demonstration of the surgical technique.
    Szlauer R; Götschl R; Razmaria A; Paras L; Schmeller NT
    Eur Urol; 2009 Feb; 55(2):368-75. PubMed ID: 19022557
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgical management of penile carcinoma in situ: results from an international collaborative study and review of the literature.
    Chipollini J; Yan S; Ottenhof SR; Zhu Y; Draeger D; Baumgarten AS; Tang DH; Protzel C; Ye DW; Hakenberg OW; Horenblas S; Watkin NA; Spiess PE
    BJU Int; 2018 Mar; 121(3):393-398. PubMed ID: 28972681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What surgical resection margins are required to achieve oncological control in men with primary penile cancer?
    Minhas S; Kayes O; Hegarty P; Kumar P; Freeman A; Ralph D
    BJU Int; 2005 Nov; 96(7):1040-3. PubMed ID: 16225525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.